Univest
Univest
  • Markets
  • eClerx Services Share Price Falls 5.10% After Q1 FY27 Results

    • August 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    eClerx Services Share Price Falls 5.10% After Q1 FY27 Results

    eClerx Services share price falls 5.10% to Rs 1,819.90 after Q1 FY27 results. Business Process Management and Analytics sector. Key analysis for investors tracking the st

    read more
  • Navin Fluorine International Share Price Gains 5.86% After Q1 FY27 Results

    • August 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Navin Fluorine International Share Price Gains 5.86% After Q1 FY27 Results

    Navin Fluorine International share price gains 5.86% to Rs 8,055.50 after Q1 FY27 results. Specialty Chemicals and Fluorine Chemistry sector. Key analysis for investors t

    read more
  • Mahindra and Mahindra Share: Pros and Cons Every Investor Must Know in 2026

    • August 6, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Mahindra and Mahindra Share: Pros and Cons Every Investor Must Know in 2026

    Mahindra and Mahindra share pros and cons: India’s SUV market leader and farm equipment king analysed for 2026. Thar dominance, EV pipeline, tractor resilience, and auto cyclicality covered.

    read more
  • Hero MotoCorp Share: Pros and Cons Every Investor Must Know in 2026

    • August 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Hero MotoCorp Share: Pros and Cons Every Investor Must Know in 2026

    Hero MotoCorp share pros and cons: Splendor maker and India’s rural two-wheeler leader analysed for 2026. Covers market dominance, EV risks, dividend yield, and Honda split legacy.

    read more
  • Colgate-Palmolive India Share: Pros and Cons Every Investor Must Know in 2026

    • August 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Colgate-Palmolive India Share: Pros and Cons Every Investor Must Know in 2026

    Colgate-Palmolive India share pros and cons: oral care market leader analysed for 2026. Covers 84 percent ROE, toothpaste dominance, herbal competition risks, and dividend yield.

    read more
  • Emami Share: Pros and Cons Every Investor Must Know in 2026

    • August 6, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Emami Share: Pros and Cons Every Investor Must Know in 2026

    Emami share pros and cons: niche FMCG with Navratna and BoroPlus brand moats at reasonable 23x PE analysed for 2026. Category monopolies, seasonal earnings, male grooming competition, and value opportunity covered.

    read more
  • HCL Technologies Share: Pros and Cons Every Investor Must Know in 2026

    • August 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    HCL Technologies Share: Pros and Cons Every Investor Must Know in 2026

    HCL Technologies share pros and cons: unique IT services plus products model, ER&D leadership, and dividend yield analysed for 2026 investors.

    read more
  • Nestle India Share: Pros and Cons Every Investor Must Know in 2026

    • August 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Nestle India Share: Pros and Cons Every Investor Must Know in 2026

    Nestle India share pros and cons: Maggi maker and Swiss FMCG giant analysed for 2026. Covers brand power, 75x PE risks, rural distribution gap, and dividend history.

    read more
  • Godrej Consumer Products Share: Pros and Cons Every Investor Must Know in 2026

    • August 6, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Godrej Consumer Products Share: Pros and Cons Every Investor Must Know in 2026

    Godrej Consumer Products share pros and cons: India insecticide leader and Africa-Indonesia FMCG player analysed for 2026. Emerging market exposure, currency risks, and high PE valuation covered.

    read more
  • Sun Pharmaceutical Industries vs Dr Reddy’s Laboratories: Which Stock Should You Track

    • August 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Sun Pharmaceutical Industries vs Dr Reddy's Laboratories: Which Stock Should You Track

    Sun Pharma vs Dr Reddy’s Laboratories compared on US generic business, specialty pharma, ROE and valuation. Full data-backed breakdown for large pharma investors.

    read more
  • 1
  • …
  • 899
  • 900
  • 901
  • 902
  • 903
  • …
  • 2,710